Pfizer mulls facility sale; GSK penalized in South Korea for administrative breach

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

Pfizer is considering selling a facility …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BMX-001 by Biomimetix JV for Hypopharyngeal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 22, 2023

Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint

Pfizer is planning to leave the Biotechnology Innovation Organization, a source familiar with the matter confirmed to Endpoints News, as it will not renew its

December 7, 2023

The only tribal medical school in the U.S. graduates its first Native American doctors

There are so few Indigenous physicians in the United States — just 0.3% of doctors — that their numbers barely show up in charts and

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.